The present invention is directed to pyrimidinone compounds of general structural formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10).
本发明涉及一般结构式(I)的
嘧啶酮化合物,其可用作治疗与
磷酸二酯酶10(PDE10)相关的中枢神经系统疾病的治疗剂。